Preparation and Optimization of Naringin Oral Nanocarrier: In Vitro Characterization and Antibacterial Activity
Source abstract
Abstract
Naringin (NG), is a poorly water-soluble flavonoid that has reported to possess a variety of therapeutic efficacies. The present research work is designed to prepare and optimize Naringin hybrid nanoparticles (NG-HNs) using lipid (A), chitosan (B), and D-α-tocopheryl polyethylene glycol succinate (C). The formulations were optimized using a Box–Behnken Design (BBD), and the selection of optimized composition (NG-HNop) was carried out on the basis of low particle size (Y1) and high entrapment efficiency (Y2) using the point prediction method. The selected NG-HNop was further evaluated in order to study permeation, drug release, antimicrobial and antioxidant effect, and cell viability. The optimized nanoparticles (NG-HNop) showed a particle size and entrapment efficiency of 246 ± 8.3 nm and 83.5 ± 2.1%, with a polydispersibility index (PDI) of 0.23 and a Zeta potential of + 18.1 mV, indicating high stability. The optimized NG-HNop exhibited better drug release (89.62 ± 4.54%) and enhanced permeation (3.7 folds). A significant improvement in the antimicrobial activity was achieved against Escherichia coli with respect to Staphylococcus aureus with the hybrid nanoparticles. They also exhibited better activity in the tested cell line. On the basis of the study results, hybrid nanoparticles of Naringin are an alternative oral delivery method for treating cancer cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems · Natural Antidiabetic Agents Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
Department of Basic Health Sciences, Preparatory Year, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia
Biology Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
Environment and Biomaterial Unit, Health Sciences Research Center, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
Saudi Society for Applied Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
Funding
Princess Nourah bint Abdulrahman University
References (46)
Show source-provided references
1. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system10.1016/j.ejps.2006.04.016 ↗
2. Alkhalidy, H., Wang, Y., and Liu, D. (2018). Dietary Flavonoids in the Prevention of T2D: An Overview. Nutrients, 10.10.3390/nu10040438 ↗
3. Flavonoids: An overview10.1017/jns.2016.41 ↗
4. Antibacterial activity of naringin derivatives against pathogenic strains10.1111/j.1365-2672.2011.05070.x ↗
5. Phenolic composition, antioxidant potential and health benefits of citrus peel10.1016/j.foodres.2020.109114 ↗
6. Therapeutic Effects of Naringin in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation10.3389/fphar.2021.672054 ↗
7. Polymeric micelles for potentiated antiulcer and anticancer activities of naringin10.2147/IJN.S154325 ↗
8. Den Hartogh, D.J., and Tsiani, E. (2019). Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol. Biomolecules, 9.10.3390/biom9030099 ↗
9. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits10.1016/S0024-3205(01)01491-6 ↗
10. Gum tragacanth stabilized green gold nanoparticles as cargos for Naringin loading: A morphological investigation through AFM10.1016/j.carbpol.2017.06.071 ↗
11. Enhanced Antibacterial Potential of Naringin Loaded β Cyclodextrin Nanoparticles10.1007/s10876-020-01972-8 ↗
12. Lipid Based nanoformulation of lycopene improves oral delivery: Formulation optimization, ex vivo assessment and its efficacy against breast cancer10.1080/02652048.2017.1340355 ↗
13. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake10.1016/j.ejpb.2017.04.013 ↗
14. Novel self-nanomicellizing formulation based on Rebaudioside A: A potential nanoplatform for oral delivery of naringenin10.1016/j.msec.2020.110926 ↗
15. Berberine-loaded liposomes for oral delivery: Preparation, physicochemical characterization and in vivo evaluation in an endogenous hyperlipidemic animal model10.1016/j.ijpharm.2022.121525 ↗
16. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel10.1016/j.biomaterials.2009.02.045 ↗
17. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD10.1186/s12951-018-0391-9 ↗
18. Zafar, A., Alruwaili, N.K., Imam, S.S., Alsaidan, O.A., Ahmed, M.M., Yasir, M., Warsi, M.H., Alquraini, A., Ghoneim, M.M., and Alshehri, S. (2022). Development and Optimization of Hybrid Polymeric Nanoparticles of Apigenin: Physicochemical Characterization, Antioxidant Activity and Cytotoxicity Evaluation. Sensors, 22.10.3390/s22041364 ↗
19. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: In-vitro and in-vivo evaluations10.2147/IJN.S40519 ↗
20. Lecithin/chitosan NPs of clobetasol-17-propionate capable of accumulation in pigskin10.1016/j.jconrel.2009.11.013 ↗
21. Lecithin–chitosan–TPGS nanoparticles as nanocarriers of (−)-epicatechin enhanced its anticancer activity in breast cancer cells10.1039/C8RA06327C ↗
22. Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis10.1016/j.ijpharm.2021.121114 ↗
23. In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery10.1080/10837450.2020.1849282 ↗
24. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity10.1016/j.ijbiomac.2015.12.077 ↗
25. Topical delivery of antifungal Brazilian red propolis benzophenones-rich extract by means of cationic lipid nanoemulsions optimized by means of Box-Behnken Design10.1016/j.jddst.2020.101573 ↗
26. Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction10.1016/j.ijpharm.2006.06.036 ↗
27. Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh, D.F., Javanmard, R., Dokhani, A., Khorasani, S., and Mozafari, M.R. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics, 10.10.3390/pharmaceutics10020057 ↗
28. Joseph, E., and Singhvi, G. (2019). Nanomaterials for Drug Delivery and Therapy, Elsevier BV.
29. Development and Validation of Liquid Chromatographic Method for Estimation of Naringin in Nanoformulation
30. Antioxidant activity of quercetin in Eudragit-coated liposomes for intestinal delivery10.1016/j.ijpharm.2019.05.007 ↗
31. Rahman, M., Islam, B., Biswas, M., and Alam, A.H.M.K. (2015). In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh. BMC Res. Notes, 8.10.1186/s13104-015-1618-6 ↗
32. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: In vitro characterization and in vivo pharmacokinetic study10.3109/10717544.2013.870260 ↗
33. Lecithin/chitosan nanoparticles for transdermal delivery of melatonin10.3109/02652048.2011.622053 ↗
34. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS10.1016/S0168-3659(02)00320-6 ↗
35. Kaempferol loaded lecithin/chitosan nanoparticles: Preparation, characterization, and their potential applications as a sustainable antifungal agent10.1080/21691401.2016.1192040 ↗
36. Formulation and evaluation of novel hybridized nanovesicles for enhancing buccal delivery of Ciclopirox olamine10.1208/s12249-020-01823-9 ↗
37. Chitosan-tailored lipidic nano constructs of Fusidic acid as a promising vehicle for wound infections: An explorative study10.1016/j.ijbiomac.2018.04.092 ↗
38. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules10.1016/j.addr.2012.10.010 ↗
39. Improved antioxidant, antimicrobial and anticancer activity of naringenin on conjugation with pectin10.1007/s13205-019-1835-0 ↗
40. Antimicrobial activity of β-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance10.1211/002235702649 ↗
41. Silver nanoparticles embedded in zeolite membranes: Release of silver ions and mechanism of antibacterial action
42. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: Optimization, in vitro characterization and cell culture studies10.1088/1361-6528/ac1098 ↗
43. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications10.1016/j.ijpharm.2017.09.061 ↗
44. Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action10.1155/2018/2952085 ↗
45. Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells10.2334/josnusd.56.119 ↗
46. Chitosan modification and pharmaceutical/biomedical applications10.3390/md8071962 ↗